In a 3-oxo-1,4-benzodiazepine-2-acetic acid series of vitronectin receptor (alpha v beta 3) antagonists containing a benzimidazole as a novel arginine mimetic, we examined the effects of benzimidazole modifications and amide substitutions on both activity and pharmacokinetics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(98)00555-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!